- Home
- ANNA vs HQL Comparison
ANNA vs HQL Comparison
Compare ANNA & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNA
- HQL
- Stock Information
- Founded
- ANNA 2007
- HQL 1992
- Country
- ANNA United States
- HQL United States
- Employees
- ANNA N/A
- HQL N/A
- Industry
- ANNA
- HQL Investment Managers
- Sector
- ANNA
- HQL Finance
- Exchange
- ANNA NYSE
- HQL Nasdaq
- Market Cap
- ANNA 366.3M
- HQL 369.6M
- IPO Year
- ANNA N/A
- HQL N/A
- Fundamental
- Price
- ANNA $7.56
- HQL $12.54
- Analyst Decision
- ANNA
- HQL
- Analyst Count
- ANNA 0
- HQL 0
- Target Price
- ANNA N/A
- HQL N/A
- AVG Volume (30 Days)
- ANNA 6.1K
- HQL 120.9K
- Earning Date
- ANNA 08-15-2025
- HQL 01-01-0001
- Dividend Yield
- ANNA N/A
- HQL 11.56%
- EPS Growth
- ANNA N/A
- HQL N/A
- EPS
- ANNA N/A
- HQL 0.79
- Revenue
- ANNA $2,064,630.00
- HQL N/A
- Revenue This Year
- ANNA N/A
- HQL N/A
- Revenue Next Year
- ANNA N/A
- HQL N/A
- P/E Ratio
- ANNA N/A
- HQL $17.08
- Revenue Growth
- ANNA N/A
- HQL N/A
- 52 Week Low
- ANNA $4.71
- HQL $11.34
- 52 Week High
- ANNA $18.70
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- ANNA N/A
- HQL 48.60
- Support Level
- ANNA N/A
- HQL $12.49
- Resistance Level
- ANNA N/A
- HQL $13.00
- Average True Range (ATR)
- ANNA 0.00
- HQL 0.21
- MACD
- ANNA 0.00
- HQL -0.02
- Stochastic Oscillator
- ANNA 0.00
- HQL 39.69
About ANNA ALEANNA INC
AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy. It is also involved in drilling, testing, and tie-in-related activities associated with three incremental Longanesi development wells.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.